IGFBP5 and chronic obstructive pulmonary disease: Previous studies have shown that IGFBP5 is involved in the development of lung diseases such as COPD and pulmonary fibrosis by regulating cellular inflammation and oxidative stress, which are also key pathological features of PM-induced lung injury (Li et al., 2021; Yasuoka et al., 2009).